//./ActionParams/@language -> $page_language ->
The Economic Times
English EditionEnglish Editionहिन्दीગુજરાતી
| 24 September, 2020, 01:53 AM IST | E-Paper
Search
+
    ENG
    • ENG - English
    • HIN - हिन्दी
    • GUJ - ગુજરાતી
    • MAR - मराठी
    • BEN - বাংলা 
    • KAN - ಕನ್ನಡ 
    • ORI - ଓଡିଆ
    • TEL - తెలుగు
    • TAM - தமிழ்

    Sun Pharmaceutical Industries Ltd.

    OPEN TRADING A/C
    • NSE
    • BSE
    Last Updated on 23 Sep, 2020, 03:59 PM IST
    502.90

    Today's Change

    -5.95 (-1.17%)

    Volume
    AVERAGE VOLUME
    5-Day
    10-Day
    30-Day

    10,846,053

    Open

    520.50

    Prev. Close

    508.85

    Day's Trend

    Low
    498.25
    High
    521.00
    • Bid
    • Mkt Cap (₹ Cr.)
    • P/E (x)
    • P/B (x)
    • Div_ Yield (%)
    • BETA
      BETA
      1 Month
      3-Months
      6-Months
      1 Year
      3-Years
    • Offer
    • Face Value (₹)1.00
    • EPS-TTM (Rs.)3.84
    • BV/share (₹)204.74
    • 52Wk L/H312.00/ 564.75
    • Avg. Daily Volatility %
      Avg. Daily Volatility %
      1 Month
      3-Months
      6-Months
      1 Year
      3-Years
    InsightsCandle Pattern| Events| Recos| Updates| News

    Sun Pharmaceutical Industries Ltd Stock Price F & O Quotes

    Buy Sun Pharma, target price Rs 617: ICICI Securities| Recos
    Buy
    Buy Sun Pharma, target price Rs 567: ICICI Direct| Recos
    Buy
    Reduce Sun Pharma, target price Rs 450: Edelweiss| Recos
    Reduce
    Buy Sun Pharma, target price Rs 585: ICICI Securities| Recos
    Buy
    Buy Sun Pharma, target price Rs 587: Geojit| Recos
    Buy
    Buy Sun Pharma, target price Rs 585: ICICI Securities| Recos
    Buy
    DART has a buy call on Sun Pharma, target price Rs 530| Recos
    Buy
    Buy Sun Pharma, target price Rs 540: Suruchi Kapoor| Recos
    Buy
    Buy Sun Pharma, target price Rs 528: ICICI Securities| Recos
    Buy
    Buy Sun Pharma, target price Rs 450: Edelweiss| Recos
    Buy
    Buy Sun Pharma, target price Rs 440: Jefferies| Recos
    Buy
    Hold Sun Pharma, target price Rs 430: HSBC| Recos
    Hold
    Buy SPARC, price target Rs 190: Kunal Bothra| Recos
    Buy
    Buy Sun Pharma, target Rs 450: CK Narayan| Recos
    Buy
    Sun Pharmaceutical Industries Ltd.Closure of Trading Window| Announcement
    Sun Pharmaceutical Industries Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
    Sun Pharmaceutical Industries Ltd.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.| Announcement
    Sun Pharmaceutical Industries Ltd.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.| Announcement
    Sun Pharmaceutical Industries Ltd.Intimation Of Record Date For Redemption Of Commercial Paper| Announcement
    Sun Pharmaceutical Industries Ltd.Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)| Announcement
    Sun Pharmaceutical Industries Ltd.Shareholder Meeting / Postal Ballot-Scrutinizers Report| Announcement
    Sun Pharmaceutical Industries Ltd.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.| Announcement
    Sun Pharmaceutical Industries Ltd.Chairman Speech At The 28Th Annual General Meeting| Announcement
    Sun Pharmaceutical Industries Ltd.Shareholder Meeting / Postal Ballot-Outcome of AGM| Announcement
    Sun Pharmaceutical Industries Ltd.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.| Announcement
    Sun Pharmaceutical Industries Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
    Sun Pharmaceutical Industries Ltd.Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate| Announcement
    Sun Pharmaceutical Industries Ltd.Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate| Announcement
    Sun Pharmaceutical Industries Ltd.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.| Announcement
    Sun Pharmaceutical Industries Ltd.Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.| Announcement
    Sun Pharmaceutical Industries Ltd.Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate| Announcement
    Sun Pharmaceutical Industries Ltd.Announcement under Regulation 30 (LODR)-Newspaper Publication| Announcement
    Sun Pharmaceutical Industries Ltd.Announcement under Regulation 30 (LODR)-Press Release / Media Release| Announcement
    Sun Pharmaceutical Industries Ltd.Notice Of 28Th Annual General Meeting Of The Company To Be Held On August 27, 2020, Is Enclosed Herewith Along With The ...| Announcement
    Sun Pharma resilient, may be a long-term buy| News

    Sun Pharmaceutical Industries Ltd. Share Price Updates

    Sun Pharmaceutical Industries Ltd. share price down by -1.17% from its previous close of Rs 508.85. Sun Pharmaceutical Industries Ltd. stock last traded price is 502.90
    Sun Pharmaceutical Industries Ltd. Share Price
    Value
    Today/Current/Last
    502.90
    Previous Day
    508.85
    What's your view on Sun Pharmaceutical Industries for the week?
    Bearish
    Bullish
    View community Outlook >>

    Be the first one to post on Sun Pharmaceutical Industries Ltd.

    Sun Pharmaceutical Industries Ltd.
    Quarterly Results

    Figures in Rs. Cr
    Jun 2020 
    % Chg (Quarterly)
    % Chg (Yearly)
    Peer Range
    Trend
    Last 12 Quarters Trend
    Sales
    7,467.19
    -7.56
    -9.59
    0.00
    7585.25
    Other Operating Income
    118.06
    10.43
    2.61
    -0.72
    118.06
    Operating Profit
    1,843.51
    35.25
    -7.62
    -14.20
    2526.83
    Other Income
    153.79
    50.44
    -27.80
    0.00
    153.79
    EBITDA
    1,997.30
    36.31
    -9.57
    -14.20
    2526.83
    Interest
    51.95
    0.33
    -50.08
    0.00
    102.00
    Depreciation
    495.92
    -13.81
    8.49
    0.00
    495.92
    Tax
    245.91
    195.96
    68.36
    -110.66
    305.90
    Net Profit
    -1,655.60
    NA
    NA
    -1655.60
    780.58
    EPS (₹)
    -6.90
    NA
    NA
    -10.81
    68.30

    Sun Pharmaceutical Industries Ltd Share Price

    Vs Peers
    Companies
    LTP
    Intraday
    1W %
    1M %
    1 QTR %
    1 YR %
    3 YR %
    5 Yr %
    Trend -
    D|M|Y
    502.90
    -1.17
    -0.99
    -4.82
    3.55
    19.55
    -4.08
    -43.32
    1016.55
    -2.23
    5.62
    1.29
    9.43
    34.14
    0.69
    -44.92
    2748.35
    -1.93
    -5.99
    -4.78
    17.65
    49.47
    53.23
    0.00
    383.90
    -2.34
    5.54
    -3.42
    5.32
    60.66
    -20.34
    0.04
    780.20
    -2.37
    -2.81
    -9.59
    -1.11
    26.51
    2.89
    12.55
    767.40
    -1.32
    5.59
    -0.55
    19.84
    66.59
    36.69
    15.99
    5107.75
    -1.16
    16.61
    13.02
    28.17
    86.55
    130.99
    27.36
    2660.95
    -2.41
    -5.46
    -4.70
    4.53
    57.76
    118.78
    80.81
    3147.55
    -2.75
    -0.29
    0.58
    36.84
    96.55
    262.45
    184.64
    2135.70
    1.03
    4.23
    6.70
    36.60
    129.61
    309.22
    188.16
    423.90
    0.44
    -1.57
    8.35
    7.02
    85.88
    143.58
    471.83
    Top Loser for the period amongst the peers
    Top Gainer for the period amongst the peers

    Sun Pharmaceutical Industries Ltd Risk Return Comparison

    with peersNew

    Sun Pharmaceutical Industries Ltd
    Financial Comparison

    with peers
    Management Efficiency
    Sun Pharmaceutical Industries Ltd 
    peer Average
    Peer Range
    Trend
    Return on Equity (%)
    8.31
    7.15
    -97.73
    37.52
    Return on Assets (%)
    6.48
    5.06
    -34.68
    37.98
    Return on capital Employed (%)
    6.17
    9.30
    -13.51
    32.77
    Fixed Assets Turnover (x)
    0.59
    0.41
    -36.70
    3.05
    Profitability and Growth
    Gross Profit Margin (%)
    15.03
    8.10
    -100.49
    43.32
    Operating Profit Margin(%)
    21.28
    14.28
    -46.07
    46.18
    Net Profit margin (%)
    11.46
    -0.11
    -357.87
    38.01
    Financial Strength
    Liquidity
    Quick Ratio (x)
    1.99
    1.99
    0.08
    37.52
    Current Ratio (x)
    2.95
    2.76
    0.21
    37.52
    Cash ratio (x)
    0.56
    0.24
    0.00
    2.43
    Solvency
    Debt Equity Ratio (x)
    0.04
    0.23
    0.00
    3.08
    Coverage Ratios
    Cash flows to long term debt (x)
    1.17
    2.79
    0.00
    24.88
    Better performer than its peers on this ratioAverage performer than its peers on this ratioUnderperformer than its peers on this ratio

    Sun Pharmaceutical Industries Ltd Share Holding as on 30-06-2020

    CategoryNo. of sharesPercentage
    Promoters1,312,134,53554.69
    ForeignInstitutions304,662,58012.70
    NBanksMutualFunds252,374,82610.52
    CentralGovt6,4300.00
    Others121,283,5785.05
    GeneralPublic178,782,1527.45
    FinancialInstitutions230,090,8699.59

    MF Ownership Of Sun Pharmaceutical Industries Ltd. Shares

    Fund Name
    Category
    No. of shares
    % Change in Shares (MOM basis)
    % of AUM
    Amount Invested (in ₹ Cr)
    ICICI Pru Value Discovery Direct-G
    Portfolio as on 31-08-2020
    Equity: Value Oriented
    28250000
    0.00%
    9.15%
    1469.71
    SBI ETF Nifty 50-D
    Portfolio as on 31-08-2020
    Equity: Large Cap
    16895589
    0.08%
    1.16%
    878.99
    ICICI Pru Equity & Debt Direct-G
    Portfolio as on 31-08-2020
    Hybrid: Aggressive Hybrid
    11306416
    -0.65%
    3.35%
    588.22
    SBI Equity Hybrid Direct-G
    Portfolio as on 31-08-2020
    Hybrid: Aggressive Hybrid
    10209237
    0.00%
    1.66%
    531.14
    ICICI Pru Bluechip Direct-G
    Portfolio as on 31-08-2020
    Equity: Large Cap
    3614165
    14.69%
    0.77%
    188.03

    Liquid, Ultra Short Term funds and FMPs are not taken into account.

    More Schemes »

    About Sun Pharmaceutical Industries Ltd.

    Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 120662.56 Crore) operating in Pharmaceuticals sector.

    Sun Pharmaceutical Industries Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 11906.74 Crore to Sales Value (95.01 % of Total Sales) and Other Operating Revenue which contributed Rs 625.19 Crore to Sales Value (4.98 % of Total Sales)for the year ending 31-Mar-2020.

    For the quarter ended 30-06-2020, the company has reported a Consolidated sales of Rs 7467.19 Crore, down -7.56 % from last quarter Sales of Rs 8078.03 Crore and down -9.59 % from last year same quarter Sales of Rs 8259.30 Crore Company has reported net profit after tax of Rs -2429.81 Crore in latest quarter.

    The company’s top management includes Mr.Dilip S Shanghvi, Mr.Gautam Doshi, Mr.Israel Makov, Mr.Kalyanasundaram Subramanian, Mr.Sailesh T Desai, Mr.Sudhir V Valia, Mr.Vivek Chaand Sehgal, Ms.Rekha Sethi. Company has S R B C & Co. LLP as its auditors As on 30-06-2020, the company has a total of 2,399,334,970 shares outstanding.

    Close X
    WatchlistPortfolio

    Current Price>: 2389.88

    Set Alert

    Loading
    Please wait...

    Date Sources:Live BSE and NSE Quotes Service: TickerPlant | Corporate Data, F&O Data & Historical price volume data: Dion Global Solutions Ltd.
    BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. NSE Quotes and Nifty are also real time and licenced from National Stock Exchange. All times stamps are reflecting IST (Indian Standard Time).
    By using this site, you agree to the Terms of Service and Privacy Policy.

    The Economic Times

    Loadingdata
    More on:
    Prices| Financials | Company Info | Reports | News | Competitors